DrugDashboards

Bleomycin

Bleomycin · BLEOMYCIN SULFATE 30 [USP'U]/1 · Powder, For Solution · Intramuscular; Intrapleural; Intravenous; Subcutaneous · NorthStar Rx LLC

NDC 16714-0908-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 30 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$78.71
Reported to Texas DSHS · 2026 annual filing · Northstar Rx Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 15 UNITS
$24.838
HCPCS J9040 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$2,123
45 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.0%chance of a new FDA shortage posting for bleomycin (other) in the next 90 days

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA205030
TE code
AP
Approval date
Apr 20, 2018
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Bleomycin (Powder, For Solution)

LabelerStrengthFirst seenLast seen
NorthStar Rx LLCBLEOMYCIN SULFATE 15 [USP'U]/1Jul 15, 2026Sep 2, 2026
NorthStar Rx LLCBLEOMYCIN SULFATE 30 [USP'U]/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Bleomycin — NDC 16714-0908-01," retrieved September 3, 2026, https://drugdashboards.com/drug/16714090801.

Free to cite with attribution — see how the data is put together.